Iamborwornkun N, Kitkumthorn N, Stevenson A, Kirk A, Graham S, Chuen-Im T
Biomed Rep. 2024; 21(2):125.
PMID: 39006509
PMC: 11240274.
DOI: 10.3892/br.2024.1813.
Yu L, Majerciak V, Zheng Z
Int J Mol Sci. 2022; 23(9).
PMID: 35563334
PMC: 9105396.
DOI: 10.3390/ijms23094943.
Mahmoudabadi G, Phillips R
Elife. 2018; 7.
PMID: 29624169
PMC: 5908442.
DOI: 10.7554/eLife.31955.
Goes L, Freitas A, Ferraz O, Rieger T, Dos Santos J, Pereira A
Braz J Microbiol. 2013; 39(1):1-4.
PMID: 24031166
PMC: 3768373.
DOI: 10.1590/S1517-83822008000100001.
Guan W, Huang Q, Cheng F, Qiu J
J Biol Chem. 2011; 286(28):24793-805.
PMID: 21622561
PMC: 3137055.
DOI: 10.1074/jbc.M111.227439.
Regulation of bovine papillomavirus type 1 gene expression by RNA processing.
Jia R, Zheng Z
Front Biosci (Landmark Ed). 2009; 14(4):1270-82.
PMID: 19273129
PMC: 2654602.
DOI: 10.2741/3307.
Control of the papillomavirus early-to-late switch by differentially expressed SRp20.
Jia R, Liu X, Tao M, Kruhlak M, Guo M, Meyers C
J Virol. 2008; 83(1):167-80.
PMID: 18945760
PMC: 2612334.
DOI: 10.1128/JVI.01719-08.
Imaging the alternative silencing of FGFR2 exon IIIb in vivo.
Bonano V, Oltean S, Brazas R, Garcia-Blanco M
RNA. 2006; 12(12):2073-9.
PMID: 17068207
PMC: 1664716.
DOI: 10.1261/rna.248506.
Papillomavirus genome structure, expression, and post-transcriptional regulation.
Zheng Z, Baker C
Front Biosci. 2006; 11:2286-302.
PMID: 16720315
PMC: 1472295.
DOI: 10.2741/1971.
A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
Rush M, Zhao X, Schwartz S
J Virol. 2005; 79(18):12002-15.
PMID: 16140776
PMC: 1212645.
DOI: 10.1128/JVI.79.18.12002-12015.2005.
Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.
Bodily J, Meyers C
J Virol. 2005; 79(6):3309-21.
PMID: 15731225
PMC: 1075705.
DOI: 10.1128/JVI.79.6.3309-3321.2005.
Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.
Zheng Z
J Biomed Sci. 2004; 11(3):278-94.
PMID: 15067211
PMC: 2442652.
DOI: 10.1007/BF02254432.
Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex.
Cumming S, McPhillips M, Veerapraditsin T, Milligan S, Graham S
J Virol. 2003; 77(9):5167-77.
PMID: 12692219
PMC: 153945.
DOI: 10.1128/jvi.77.9.5167-5177.2003.
Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X, Mayeda A, Tao M, Zheng Z
J Virol. 2003; 77(3):2105-15.
PMID: 12525645
PMC: 140879.
DOI: 10.1128/jvi.77.3.2105-2115.2003.
Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.
Collier B, Oberg D, Zhao X, Schwartz S
J Virol. 2002; 76(6):2739-52.
PMID: 11861841
PMC: 135970.
DOI: 10.1128/jvi.76.6.2739-2752.2002.
Identification of alternative splicing and negative splicing activity of a nonsegmented negative-strand RNA virus, Borna disease virus.
Tomonaga K, Kobayashi T, Lee B, Watanabe M, Kamitani W, Ikuta K
Proc Natl Acad Sci U S A. 2000; 97(23):12788-93.
PMID: 11070091
PMC: 18842.
DOI: 10.1073/pnas.97.23.12788.
Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
Zheng Z, Reid E, Baker C
J Virol. 2000; 74(22):10612-22.
PMID: 11044105
PMC: 110935.
DOI: 10.1128/jvi.74.22.10612-10622.2000.
Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.
Zheng Z, Quintero J, Reid E, Gocke C, Baker C
J Virol. 2000; 74(13):5902-10.
PMID: 10846071
PMC: 112086.
DOI: 10.1128/jvi.74.13.5902-5910.2000.
Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability.
Zhou J, Liu W, Peng S, Sun X, Frazer I
J Virol. 1999; 73(6):4972-82.
PMID: 10233959
PMC: 112541.
DOI: 10.1128/JVI.73.6.4972-4982.1999.
Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site.
Zheng Z, He P, Baker C
J Virol. 1998; 73(1):29-36.
PMID: 9847303
PMC: 103804.
DOI: 10.1128/JVI.73.1.29-36.1999.